For example, the GLP-1 analogue liraglutide (which is marketed both for treatment of type-2 diabetes and obesity) was injected intraperitoneally (i.p.)in mice, and later on the levels of this drug were measured in the brain. This evidence concerns the gene GCG and type 2 diabetes mellitus.